An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer

Overview

The real-world observational study was designed to explore lymph metastases and prognoses of the Chinese patients with thoracic T1-T3 esophageal cancer

Full Title of Study: “A Real-world Observational Study to Evaluate Lymph Metastases and Prognoses of the Chinese Patients With Thoracic T1-T3 Esophageal Cancer”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: April 30, 2018

Detailed Description

This trial is a real-world non-interventional observational study. The Chinese patients with thoracic T1-T3 esophageal cancer enrolled from Jan.1999 to Jun.2017 were included and the study data on pathologically diagnosed patient demographic/tumor biological characteristics were collected to evaluate the relevance of lymph metastases and prognoses of the subjects.

Interventions

  • Procedure: Surgeries
    • Radical resection of esophageal cancer

Arms, Groups and Cohorts

  • T1-T3 esophageal cancer
    • Pathologically diagnosed patients with T1-T3 esophageal cancer who received surgeries

Clinical Trial Outcome Measures

Primary Measures

  • Numbers of lymph nodes and percentages of patients with surgeries
    • Time Frame: 1999 – 2017
    • Numbers of lymph nodes and percentages of patients with surgeries in the patients with thoracic T1-T3 esophageal cancer

Secondary Measures

  • Impact factors of lymph metastases
    • Time Frame: 1999 – 2017
    • Impact factors of lymph metastases

Participating in This Clinical Trial

Inclusion Criteria

  • Patients >= 18 years old;
  • Patients who received radical resection of esophageal cancer;
  • Pathologically diagnosed patients with thoracic T1-T3 esophageal cancer after surgeries;

Exclusion Criteria

  • Patients who received upper gastrointestinal surgeries;
  • Patients with second primary tumors;

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Henan Cancer Hospital
  • Collaborator
    • LinkDoc Technology (Beijing) Co. Ltd.
  • Provider of Information About this Clinical Study
    • Principal Investigator: Yin Li, Professor – Henan Cancer Hospital
  • Overall Official(s)
    • Yin Li, Principal Investigator, Henan Cancer Hospital
  • Overall Contact(s)
    • Haiying Yang, 0086-10-62680809, celineyang@linkdoc.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.